PI3K (p110-alpha/p85-alpha), actif, associé à la souris et à l'humain, PRECISIO, recombinant, exprimé en cellules baculovirus infectées par Sf9, >=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5280-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

The PI3K comprises of a 110 kDa catalytic subunit and a 85 kDa regulatory subunit. A number of isoforms of the 110 kDa catalytic subunit and the 85 kDa re...


en savoir plus

Votre prix
$356.32 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

The PI3K comprises of a 110 kDa catalytic subunit and a 85 kDa regulatory subunit. A number of isoforms of the 110 kDa catalytic subunit and the 85 kDa regulatory subunit exist in cells. The p110 alpha catalytic subunit (PIK3CA) is frequently mutated or amplified in a variety of cancers including ovarian and colon. PIK3CA gene copy number is increased in over 30% of ovarian cancers and this leads to increased PI3-kinase activity. Furthermore, the activity of p110 alpha is essential for vascular development and inactivation of p110 alpha leads to severe defects in angiogenic sprouting and vascular remodeling.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

application(s)cell analysis
assay≥70% (SDS-PAGE)
biological sourcehuman, mouse
formbuffered aqueous glycerol solution
Gene Informationmouse ... Pik3ca(18706)
mol wt~86 kDa (p85α), ~111 kDa (p110α)
NCBI accession no.NM_008839
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity64-97 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: